Here are three things to know.
- The valve is intended for use in surgical aortic valve replacement.
- The implant features anticalcification tissue properties, an expandable frame and capabilities for future valve-in-valve procedures.
- Edwards’ Lifesciences will launch the heart valve in early 2018.
More articles on supply chain:
Precision benchmarking a panacea for purchased services savings
Vertex Pharma makes 1st price hike on cystic fibrosis drug
Novo Nordisk recalls insulin pen cartridge holders
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
